Daniel S. Lorrain sold $17K of Contineum Therapeutics, Inc. (CTNM) stock

Daniel S. Lorrain, Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM), sold 1,040 shares of CTNM stock worth $17K, per an SEC Form 4 filed Jul 10, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 8, 2026, 2 days before it was made public.

CTNM has moved -13.4% since the trade date, from $15.65 to $13.55 (Sep 21, 2026 close).